Results 131 to 140 of about 37,229 (248)
Indexing for body surface area when assessing kidney function. [PDF]
Mohamed AAA +4 more
europepmc +1 more source
Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review
ABSTRACT The glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are a relatively new class of drugs that were initially approved by the US Food and Drug Administration to improve glycemic control in patients with type 2 diabetes mellitus and, subsequently, weight reduction in patients with obesity.
Audrey Y. Chang, Farrah J. Mateen
wiley +1 more source
Electrode-Level Low-Dimensionality Does Not Guarantee Sensor Redundancy: Dual-Dataset, Participant-Grouped Validation of Parsimonious Myoelectric Gesture Decoding. [PDF]
Çalıkuşu İ.
europepmc +1 more source
ABSTRACT Objective To compare the incidence of diabetes mellitus and its associations with hospitalisation and mortality in adults with multiple sclerosis (MS) and matched controls. Methods Using English primary care data from the Clinical Practice Research Datalink, linked to hospital and mortality records, we matched adults with MS with up to 10 ...
Yolanda Lau +8 more
wiley +1 more source
The illusion of academic visibility: database selectivity, language hierarchies, and citation inequality in small-state legal scholarship. [PDF]
Marolov D, Trajkovska E.
europepmc +1 more source
Investigation of Complement Activation and Cytokine Signatures in AQP4+ NMOSD, MOGAD, and MS
ABSTRACT Objective Aquaporin‐4‐IgG seropositive neuromyelitis optica spectrum disorder (AQP4+ NMOSD), myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD), and multiple sclerosis (MS) are pathophysiologically distinct neuroinflammatory disorders. Complement activation is a major mechanism of injury in AQP4+ NMOSD, whereas its role in
Angeliki G. Filippatou +23 more
wiley +1 more source
Mapping Lacrosse Injury and Sports Medicine Research. [PDF]
Bosh L +3 more
europepmc +1 more source

